Healthcare -
Biotechnology - NASDAQ - US
$ 39.9894
6.12 %
$ 6.35 B
Market Cap
157.2
P/E
TGTX - OPERATING INCOME
Operating Income TGTX - TG Therapeutics, Inc.
41.9 M
LAST VALUE
48.91%
2 YEAR CAGR
17.59%
5 YEAR CAGR
10.66%
10 YEAR CAGR